0.5900USD0.00%Mkt Cap: 5.68M USDP/E: —Last update: 2026-05-29
Orgenesis Inc., a biotech company, focuses on cell and gene therapies in the United States. It operates through two segments: Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap5.68M USD
Enterprise Value22.84M USD
Revenue (TTM)1.03M USD
Gross Profit-8.47M USD
Net Income (TTM)-48.16M USD
Revenue/Share0.2460 USD
Last Price0.5900 USD
Fiscal Year EndDec 2024
MR QuarterSep 2024
Employees77
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)0.95
PEG—
EV/EBITDA-0.95
EV/Revenue22.07
P/S5.49
P/B-0.08
EPS (TTM)-11.44
EPS (Forward)0.61
52W Range
0.010026% of range2.270
52W High2.270 USD
52W Low0.0100 USD
Profitability
Gross Margin-818.55%
Oper. Margin-2196.25%
EBITDA Margin0.00%
Profit Margin-4653.62%
ROE128.44%
ROA-3565.14%
Growth
Revenue Growth215.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-17.08M USD
CapEx (TTM)263.00K USD
FCF Margin-524.83%
FCF Yield-95.57%
Net Debt17.09M USD
Net Debt/EBITDA-0.71
Balance Sheet
Debt/Equity-0.49
Current Ratio0.03
Quick Ratio0.00
Book Value/Sh-7.2520 USD
Cash/Share0.0210 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateNov 16, 2017
Splits
Last Split1:10
Split DateSep 25, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.9.80M
Float8.23M
Insiders46.36%
Institutions0.52%
Short Interest
Short Ratio2.4d
Short % Float1.33%
Short % Out.1.18%
Shares Short56.25K
Short (prev mo.)40.51K
Technical
SMA 500.3834 (+53.9%)
SMA 2000.3947 (+49.5%)
Beta3.07
S&P 52W Chg27.94%
Avg Vol (30d)1.85K
Avg Vol (10d)2.74K
Technical Indicators
RSI (14)55.3
MACD0.0121
MACD Signal-0.0239
MACD Hist.+0.0359
BB Upper0.7929 USD
BB Middle0.3555 USD
BB Lower-0.0819 USD
BB Width246.09%
ATR (14)0.3411 USD
Vol Ratio (20d)0.05x